Mauro Galeazzi Selected Research

Interleukins

1/2020	The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.
7/2018	Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
10/2017	The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.
7/2017	IL-6 blockade in the management of non-infectious uveitis.
1/2017	Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.
1/2017	Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
7/2015	Anakinra treatment in drug-resistant Behcet's disease: a case series.
1/2015	Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease.
5/2014	Working the endless puzzle of hereditary autoinflammatory disorders.
5/2013	The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Galeazzi Research Topics

Disease

42	Rheumatoid Arthritis 04/2020 - 06/2004
18	Uveitis 01/2020 - 08/2010
15	Necrosis 01/2020 - 02/2007
13	Rheumatic Diseases (Rheumatism) 04/2020 - 06/2007
13	Osteoarthritis 01/2018 - 06/2007
13	Infections 01/2017 - 09/2003
12	Inflammation (Inflammations) 01/2017 - 08/2004
11	Pain (Aches) 11/2017 - 02/2007
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015 - 05/2002
9	Arthritis (Polyarthritis) 12/2019 - 10/2008
9	Fever (Fevers) 01/2015 - 07/2012
7	autosomal dominant familial Periodic fever 07/2017 - 06/2012
7	Knee Osteoarthritis 01/2017 - 02/2010
6	Autoimmune Diseases (Autoimmune Disease) 04/2016 - 10/2003
6	Systemic Scleroderma (Systemic Sclerosis) 03/2016 - 01/2008
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2016 - 10/2003
6	Fibrosis (Cirrhosis) 01/2016 - 01/2008
5	Thrombosis (Thrombus) 09/2019 - 01/2008
5	Vasculitis (Vasculitides) 01/2018 - 04/2010
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2017 - 06/2007
4	Psoriatic Arthritis 01/2020 - 01/2013
4	Behcet Syndrome (Behcet's Syndrome) 01/2020 - 07/2015
4	Ankylosing Spondylitis 09/2019 - 01/2014
4	Virus Diseases (Viral Diseases) 02/2014 - 10/2008
4	Osteoporosis 12/2013 - 09/2003
3	Joint Diseases (Joint Disease) 10/2017 - 04/2011
3	Cryopyrin-Associated Periodic Syndromes 10/2017 - 11/2012
3	Amyloidosis 07/2017 - 02/2012
3	Cardiac Arrhythmias (Arrythmia) 01/2017 - 01/2008
3	Gout 05/2016 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 06/2015 - 01/2015
3	Pericarditis 01/2015 - 07/2012
3	Bone Resorption 11/2014 - 03/2013
3	Mevalonate Kinase Deficiency 12/2013 - 11/2012
3	Congenital heart block 10/2011 - 01/2008
2	Sacroiliitis 11/2019 - 09/2019
2	Thrombophilia 09/2019 - 05/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2019 - 01/2015
2	Atherosclerosis 09/2019 - 03/2013
2	Non-Radiographic Axial Spondyloarthritis 09/2019 - 07/2015
2	Axial Spondyloarthritis 09/2019 - 07/2018
2	Neoplasms (Cancer) 08/2019 - 05/2010
2	Overweight 03/2019 - 10/2017
2	Panuveitis 02/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

24	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 02/2007
15	Biological ProductsIBA 04/2020 - 06/2014
14	Pharmaceutical PreparationsIBA 12/2019 - 10/2008
13	Adalimumab (Humira)FDA Link 02/2019 - 06/2012
12	Infliximab (Remicade)FDA Link 02/2019 - 02/2007
12	AntibodiesIBA 11/2017 - 04/2004
11	InterleukinsIBA 01/2020 - 08/2010
11	AutoantibodiesIBA 11/2017 - 05/2002
10	Abatacept (Orencia)FDA Link 04/2020 - 01/2014
10	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2019 - 08/2006
9	Interleukin-1 (Interleukin 1)IBA 01/2020 - 11/2012
9	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 09/2003
9	Etanercept (Enbrel)FDA Link 01/2018 - 02/2007
9	CytokinesIBA 10/2015 - 08/2011
8	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 07/2012
8	Antirheumatic Agents (DMARD)IBA 03/2019 - 12/2012
7	ametantrone (HAQ)IBA 11/2017 - 02/2007
6	SteroidsIBA 07/2019 - 12/2012
6	Intravenous Immunoglobulins (IVIG)FDA Link 08/2018 - 12/2004
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2013 - 07/2007
5	C-Reactive ProteinIBA 09/2019 - 02/2007
5	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2013
5	AdipokinesIBA 03/2019 - 11/2011
5	CannabinoidsIBA 03/2016 - 09/2009
5	InflammasomesIBA 01/2015 - 01/2013
5	Methotrexate (Mexate)FDA LinkGeneric 12/2014 - 05/2010
4	golimumab FDA Link 01/2020 - 07/2017
4	canakinumab FDA Link 01/2020 - 06/2012
4	Tumor Necrosis Factor InhibitorsIBA 11/2019 - 05/2013
4	tocilizumab (atlizumab)FDA Link 03/2019 - 09/2013
4	Interleukin-6 (Interleukin 6)IBA 03/2019 - 08/2008
4	Rheumatoid FactorIBA 10/2017 - 05/2016
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2017 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 03/2016 - 06/2004
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2019 - 01/2008
3	Anticardiolipin AntibodiesIBA 09/2019 - 01/2008
3	Monoclonal AntibodiesIBA 03/2019 - 01/2017
3	AdiponectinIBA 03/2019 - 03/2013
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 08/2004
3	AntigensIBA 11/2017 - 04/2010
3	Rituximab (Mabthera)FDA Link 01/2017 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2007
3	Fluorescein (Funduscein)FDA LinkGeneric 01/2017 - 01/2017
3	CollagenIBA 01/2016 - 03/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016 - 04/2011
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2015 - 09/2012
3	Colchicine FDA LinkGeneric 05/2015 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2006
2	Biosimilar PharmaceuticalsIBA 12/2019 - 10/2016
2	factor V LeidenIBA 09/2019 - 05/2016
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2019 - 05/2015
2	Prothrombin (Factor II)IBA 09/2019 - 05/2016

Therapy/Procedure

47	Therapeutics 11/2019 - 06/2004
5	Biological Therapy 12/2019 - 05/2015
5	Mud Therapy (Mud Bath) 01/2017 - 01/2011
2	Precision Medicine 01/2020 - 01/2013